#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Allogenic stem cell transplantation Angiosarcoma Acute graft versus host disease in skin Pulmonary tuberculosis Dementia Alzheimer's type Squamous cell carcinoma of head and neck Hypotransferrinaemia Retinal dystrophy Biliary cancer metastatic KBG syndrome Progressive multifocal leukoencephalopathy Extra-osseous Ewing's sarcoma metastatic Bronchopulmonary aspergillosis Craniopharyngioma Oesophageal squamous cell carcinoma stage II More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Treatment Pleural mesothelioma malignant – Treatment Andersen-Tawil syndrome – Diagnostics Haemophilia A with anti factor VIII Congenital nephrogenic diabetes insipidus Isodicentric chromosome 15 syndrome – Life with Disease Rhabdomyosarcoma – Trials in Disease Hepatoblastoma KBG syndrome – Diagnostics Encephalitis autoimmune – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ly3537982 Timolol Prilocaine Enx-101 Hydroxycarbamide Potato Starch Csm-Gw Cefepime HUPERZINE A Vancomycin Hydrochloride 204-NETU Zanamivir Rozanolixizumab WEF-001 Antithymocyte Immunoglobulin Barzolvolimab Omp66 ZILEBESIRAN Cholic Acid Bms-986340 More therapies…

    Learn about Your Condition

    Mantle cell lymphoma stage II Compulsive sexual behaviour Herpes virus infection Hyperchylomicronaemia Ewing's sarcoma Renal cell carcinoma Gallbladder cancer Craniosynostosis Inclusion body myositis Diabetic neuropathy HER2 positive gastric cancer Hepatocellular carcinoma Hepatic adenoma Tonsillitis Ichthyosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Safety of Bomedemstat for Patients with Myeloproliferative Neoplasms Who Participated in a Previous Bomedemstat Study

    Recruiting

    3 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    • Myelofibrosis
    • Polycythaemia vera
    Investigated Drugs:
    • Bomedemstat
    Italy

  • Study on Abatacept for Patients with IgG4-Related Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Immunoglobulin G4 related disease
    Investigated Drugs:
    • Abatacept
    Italy

  • Study on the Effects of Ficlatuzumab and Cetuximab for Adults with Recurrent or Metastatic HPV-Negative Head and Neck Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Ficlatuzumab
    • Cetuximab
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

    Recruiting

    2 1
    Investigated Diseases:
    • Coeliac disease
    Investigated Drugs:
    • Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
    Austria Croatia Finland Germany Ireland Italy +5

  • Study on CD19-CAR T Cells, Fludarabine, and Cyclophosphamide for Children and Young Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    Investigated Drugs:
    • Cd19-Car_Lenti_Allo
    • Fludarabine Phosphate
    • Cyclophosphamide
    Italy

  • Study of Emrusolmin for Treating Adults with Multiple System Atrophy

    Recruiting

    2 1
    Investigated Diseases:
    • Multiple system atrophy
    Investigated Drugs:
    • Emrusolmin
    France Germany Italy Spain
Previous Page
1 … 468 469 470 471 472 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!